ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Monday, November 9, 2020

9:00AM-11:00AM: Abstract Number: 1533

Ultrasound Joint Inflammation but Not Disease Activity Score at 28 Joints Is Reflective of the Severity of Joint Damage in Patients with Rheumatoid Arthritis

Imaging of Rheumatic Diseases Poster

9:00AM-11:00AM: Abstract Number: 1546

Ultrasound, Magnetic Resonance Imaging and Radiography of the Fingers’ Joints of Psoriatic Arthritis Patients

Imaging of Rheumatic Diseases Poster

9:00AM-11:00AM: Abstract Number: 1689

Unexpectedly High Incidence of Kawasaki Disease in a Well-Characterized Population in Atlantic Canada

Pediatric Rheumatology – Clinical Poster III: SLE, Vasculitis, & JDM

9:00AM-11:00AM: Abstract Number: 1816

Urine Biomarkers of Tubulointersitital Damage in Lupus Nephritis

SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside

9:00AM-11:00AM: Abstract Number: 1614

Use of a Best Practice Alert to Encourage Transition Planning and Readiness

Measures & Measurement of Healthcare Quality Poster

9:00AM-11:00AM: Abstract Number: 1597

Use of a Clinical Dashboard Improves the Documentation of Disease Severity Scores and May Facilitate the Implementation of Treat to Target Therapy

Measures & Measurement of Healthcare Quality Poster

9:00AM-11:00AM: Abstract Number: 1782

Use of a Patient-reported Survey to Document Contraceptive Use and Interest in Pregnancy to Identify Patients with Unmet Pregnancy Prevention and Planning Needs

Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: Abstract Number: 1785

Use of Contraceptive Methods in Mexican Women with Rheumatic Diseases

Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: Abstract Number: 1894

Use of Facebook and Electronic Patient Portal to Identify Axial Spondyloarthritis in Patients with Chronic Back Pain

Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

9:00AM-11:00AM: Abstract Number: 1646

Use of Prescription Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Adults with Hip/Knee Osteoarthritis (OA) at Increased Risk for NSAID-related Adverse Events

Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: Abstract Number: 1537

Usefulness of Ultrasound Assessment of Sarcopenia in Patients with Rheumatoid Arthritis

Imaging of Rheumatic Diseases Poster

9:00AM-11:00AM: Abstract Number: 1595

Using Rheumatoid Arthritis Communication Tool Developed by the RISE Learning Collaborative to Promote Shared Decision-Making

Measures & Measurement of Healthcare Quality Poster

9:00AM-11:00AM: Abstract Number: 1772

Vaccinations of Infants Born to Mothers on TNF Inhibitors: Safe Administration of Live-vaccines Given Per the National Immunization Program

Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: Abstract Number: 1929

Visual Ischemia During Relapse and Follow-up of Giant Cell Arteritis: A Systematic Review

Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

9:00AM-11:00AM: Abstract Number: 1802

Vitamin D Level: Predictor of SLE Disease Activity in AA Cohort with CLE?

SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].